Exposure-response relationship during vedolizumab induction therapy in adults with ulcerative colitis

被引：0
|
作者：
Rosario, M. [1 ]
French, J. [2 ]
Dirks, N. [2 ]
Milton, A. [1 ]
Fox, I. [1 ]
Gastonguay, M. [2 ]
机构：
[1] Takeda Pharmaceut Int Co, Clin Pharmacol, Cambridge, MA USA
[2] Metrum Res Grp LLC, Biotechnol, Tariffville, CT USA
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P489
引用
收藏
页码：S270 / S271
页数：3
相关论文
共 50 条
  • [41] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
    Pellet, Gauthier
    Stefanescu, Carmen
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    Allimant, Christophe
    Nachury, Maria
    Nancey, Stephane
    Filippi, Jerome
    Altwegg, Romain
    Brixi, Hedia
    Fotsing, Ginette
    de Rosamel, Laure
    Shili, Sarah
    Laharie, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 494 - 501
  • [42] Pharmacokinetics and Exposure-Response Relationship of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase2/3 Induction and Maintenance Studies
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Marano, Colleen W.
    Strauss, Richard
    Zhang, Hongyan
    Johanns, Jewel
    Ford, Joyce A.
    Zhou, Honghui
    Davis, Hugh M.
    Colombel, Jean-Frederic
    Reinisch, Walter
    Feagan, Brian G.
    Rutgeerts, Paul J.
    Sandborn, William
    GASTROENTEROLOGY, 2013, 144 (05) : S228 - S229
  • [43] Exposure-Response Relationship for Certolizumab Pegol During the Induction Phase in Patients With Crohn's Disease
    Vande Casteele, Niels
    Stitt, Larry
    Spearman, Marshall
    Kosutic, Gordana
    Oliver, Ruth
    Coarse, Jason
    Feagan, Brian G.
    Sandborn, William
    GASTROENTEROLOGY, 2016, 150 (04) : S409 - S409
  • [44] Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis
    D'Haens, Geert
    Rosario, Maria
    Polhamus, Daniel
    Dirks, Nathanael L.
    Chen, Chunlin
    Kisfalvi, Krisztina
    Agboton, Christian
    Vermeire, Severine
    Feagan, Brian G.
    Sandborn, William J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (04) : 403 - 412
  • [45] Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis
    Thakre, Neha
    Goebel, Aline
    Winzenborg, Insa
    Suleiman, Ahmed A.
    D'Cunha, Ronilda
    Mensing, Sven
    Liu, Wei
    Pang, Yinuo
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (03) : 847 - 857
  • [46] Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Marano, Colleen W.
    Strauss, Richard
    Zhang, Hongyan
    Johanns, Jewel
    Zhou, Honghui
    Davis, Hugh M.
    Reinisch, Walter
    Feagan, Brian G.
    Rutgeerts, Paul
    Sandbom, William J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (01): : 35 - 46
  • [47] Vedolizumab: Real-life outcomes to therapy in ulcerative colitis
    Pulusu, S. S. R.
    Krishnaprasad, K.
    Cheng, D.
    Mogilevski, T.
    Flanagan, E.
    Parthasarathy, N.
    Wu, C.
    Prosser, R.
    Sawyer, E.
    Rizvi, Q-U-A
    Taylor, K.
    Sewell, K.
    Cooke, S.
    Mahy, G.
    Radford-Smith, G.
    Sparrow, M.
    Andrews, J.
    Connor, S.
    Bampton, P.
    Ghaly, S.
    Van Langenberg, D.
    Bell, S.
    De Cruz, P.
    Begun, J.
    Lawrance, I.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 142 - 142
  • [48] Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy
    Le Berre, Catherine
    Loeuille, Damien
    Peyrin-Biroulet, Laurent
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (04) : 794 - 796
  • [49] Combined therapy of tacrolimus and vedolizumab in severe refractory ulcerative colitis
    Dietrich, N. -A.
    Baer, F.
    Dignass, A.
    Bokemeyer, B.
    Fellermann, K.
    Buening, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S394 - S394
  • [50] A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis
    Dreesen, Erwin
    Kantasiripitak, Wannee
    Detrez, Iris
    Stefanovic, Sebastian
    Vermeire, Severine
    Ferrante, Marc
    Bouillon, Thomas
    Drobne, David
    Gils, Ann
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (04) : 570 - 580
12345